| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A new era in prostate cancer therapy: new targets and novel therapeutics
|
Bradley, Deborah A.
|
|
2007
|
3 |
1 |
p. 31-39
|
article
|
| 2 |
Biological significance of myeloperoxidase (MPO) on green tea component, (−)-epigallocatechin-3-gallate (EGCG)-induced apoptosis: its therapeutic potential for myeloid leukemia
|
Kizaki, Masahiro
|
|
2007
|
3 |
1 |
p. 45-50
|
article
|
| 3 |
ErbB1–ErbB4 nuclear and cytoplasmic overexpression, ethnicity and predicted outcome in prostate cancer
|
Ben-Yosef, R.
|
|
2007
|
3 |
1 |
p. 13-17
|
article
|
| 4 |
From suntan to skin cancers: molecular pathways and prevention strategies
|
Fisher, Jonathan M.
|
|
2007
|
3 |
1 |
p. 41-44
|
article
|
| 5 |
From the bench to the bedside: emerging new treatments in multiple myeloma
|
Hayden, Patrick J.
|
|
2007
|
3 |
1 |
p. 19-29
|
article
|
| 6 |
New therapies in squamous cell carcinoma of the head and neck: is the future in combined therapies?
|
Schneider, Maurice
|
|
2007
|
3 |
1 |
p. 1-2
|
article
|
| 7 |
Optimizing antiangiogenic strategies: combining with radiotherapy
|
Cohen-Jonathan Moyal, E.
|
|
2007
|
3 |
1 |
p. 51-56
|
article
|
| 8 |
Phase I and pharmacokinetic study of vatalanib plus capecitabine in patients with advanced cancer
|
Schilsky, Richard L.
|
|
2007
|
3 |
1 |
p. 3-11
|
article
|
Journal description